It has minimal effect on β globin synthesis because of which basic hematological parameters and Hb A2 levels remain in normal range and patients are clinically asymptomatic. This mutation, therefore, can only be identified at the molecular level. 1 Importance of Cap +1 mutation is that if it exists in a compound heterozygous state with β thalassemia minor, it may present as thalassemia major or intermedia. [1] This mutation was however absent in the index case, indicating that the phenotypic variation of δβ thalassemia in the index case was due to some other causes.
The variation in clinical severity may be due to the effect of genetic modifiers. [2, 3] The probable causes could be genetic variation of chromosome 6 which affects the HbF levels, or single-nucleotide polymorphism of the β globin gene or a new mutation in the index case which was not picked up by the molecular techniques applied. An extended molecular analysis is needed in such patients to define the genotype for different genetic modifiers and to understand their phenotypic modulation abilities.
Thus, this case is being reported because it is an example of unexplained phenotypic heterogeneity of δβ thalassemia.
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Sickled red blood cells in urine: A preliminary indicator for the detection of sickle cell trait
Editor, Sickled erythrocytes (SEry) on peripheral blood smear (PBS) followed by positive sickling or solubility test are commonly used as a screening test, while hemoglobin (Hb) electrophoresis or high-performance liquid chromatography (HPLC) confirms the diagnosis of sickle cell disease (SCD). SEry in urine have been rarely reported so far. [1] [2] [3] [4] We report an interesting case of a patient with normal hemogram and red blood cell (RBC) morphology on PBS. It was the finding of SEry on urine microscopy which served as the first clue to the diagnosis of sickle cell trait (SCT) which was then confirmed by HPLC.
A 15-year-old female presented with an episode of generalized tonic clonic seizure and altered sensorium since 1 day followed by regain of consciousness without any focal neurological deficit. She also gave a history of headache and sore throat 1 week back. Hematuria is by far the most common complications of SCT. [1] It is far more common in heterozygotes than in homozygotes as SCT is 30-40 times more frequent than SCA. [1] Sickling of erythrocytes within the hypoxic, hypertonic, and acidotic environment of renal medulla followed by stasis within the peritubular capillaries with extravasation of RBCs into the tubular lumina is the possible initiating mechanism of hematuria. [1] The finding of SEry in urine of our patient was the initial clue to the diagnosis of SCD. Sickle cells in urine have been described in the urinary sediment of 10 patients with SCD/SCT with either gross or microscopic hematuria so far. [1] [2] [3] [4] However, it is only in three of these cases that the potential diagnostic role of these cells was considered [1, 2, 4] [ Table 1 ].
The observations of this case are clinically very important in a country like India with such high prevalence of SCD among specific population groups who are unaware, have their own cultural and social systems, and where delivering healthcare is a challenge. Poor facilities for diagnosis, genetic counseling, and prenatal detection add to the burden. With high percentage of patients with SCT exhibiting hematuria, finding sickled RBCs in urine would serve as a simple, quick, low-cost screening method of identifying these cases. Although it cannot be used for screening in population-based programs, SEry in urine if found should never be ignored, as they could be the only clue to the diagnosis of an unsuspected case of SCD.
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Departments of Clinical Pathology and 1 Medicine, Lok Nayak Hospital, New Delhi, India history was also negative with respect to any neurological, renal, or hematological disorders. Her hemogram was normal (Hb 13.1 g/dL, RBC count 4.72 × 10 6 /µL, hematocrit 39.3%, total leucocyte count 8,010/µL, platelet count 191,000/µL) with normocytic normochromic RBCs on PBS. The urine sample received was 20 mL in volume, red in color, with a pH of 6. Chemical examination of urine using dipstick testing showed presence of traces of albumin, whereas glucose, ketone bodies, bile pigments, and urobilinogen were absent. Urine microscopy revealed 10-15 pus cells, 3-4 epithelial cells, and 20-25 RBC per high power field. Fair number of the RBCs were sickle-shaped [ Figure 1 ]. HPLC performed after urinary findings showed HbF 4.4%, HbA 54.6%, HbA 2 2.1%, HbD 0%, and HbS 38.9%. On the basis of laboratory findings, final diagnosis of hematuria associated with SCT (Hb-AS) was given and the patient was managed conservatively.
Worldwide prevalence of SCT is 5% with a higher prevalence in India ranging from 1% to 40% among different tribal groups. [5] This is because of practice of consanguineous marriage making individuals prone to genetic disorders. [5] The highest prevalence has been reported from tribes of south Gujarat, Maharashtra, Chhattisgarh, Odisha, and Madhya Pradesh. [5] It is very important to detect these carriers to prevent the birth of a child with homozygous sickle cell anemia (SCA), sickle-β-thalassemia, or HbSD thalassemia which present with severe disease. Preventing the birth of affected children through population/targeted screening and genetic counseling is the best possible strategy for prevention of these disorders. Savige et al. [4] 33 /female  Greek  4 weeks  Present  -SCT  1996 Fogazzi et al. [1] 16/male South African Recurrent bouts Present Normal SCT 2017
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